Enveric Biosciences, Inc.

NasdaqCM ENVB

Enveric Biosciences, Inc. Cash and Short-Term Investments for the quarter ending September 30, 2024

Enveric Biosciences, Inc. Cash and Short-Term Investments is NA for the quarter ending September 30, 2024. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.
  • Enveric Biosciences, Inc. Cash and Short-Term Investments for the quarter ending September 30, 2022 was USD 21.20 M.
  • Enveric Biosciences, Inc. Cash and Short-Term Investments for the quarter ending September 30, 2020 was USD 2.84 M, a 468.38% change year over year.
Key data
Date Cash and Short-Term Investments Receivables Inventory Goodwill
Market news
SV Wall Street
NasdaqCM: ENVB

Enveric Biosciences, Inc.

CEO Dr. Joseph Edward Tucker Ph.D.
IPO Date May 4, 2015
Location United States
Headquarters 4851 Tamiami Trail North
Employees 7
Sector Healthcare
Industries
Pharmaceuticals Biotechnology Clinical Trials Cosmetics Drugstores & Retail Pharmacies Mental Health Personal Care Tobacco
Description

Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.

Similar companies

ZURA

Zura Bio Limited

USD 1.78

4.09%

StockViz Staff

February 6, 2025

Any question? Send us an email